Risk factor
Very high price volatility
Profitability factor
Undervalued vs peers
About
IDenta Corp. specializes in the development, manufacturing, and global distribution of advanced diagnostic and forensic testing solutions. The company's portfolio includes both field-based detection kits and at-home screening tools, primarily focused on identifying narcotics, explosives, and other substances relevant to homeland security and consumer applications. Their diverse product range features specialized kits for drug detection, explosive residue analysis, and bullet-hole identification. Furthermore, IDenta offers FerroPrint testing products, blood detection systems, kits to identify drug precursors, and portable sniffers for mobile screening. These crucial solutions are provided to a wide array of clients, including law enforcement, military forces, and governmental organizations. The company also supports other entities actively engaged in the fight against illicit drugs and terrorist threats. IDenta Corp., founded in 1997, is headquartered in Jerusalem, Israel.
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, trad